CD4 and cancer: After the multialgorithm comprehensive analyses, types of immune cells enriched in low-risk group are inclusive of B cell according to TIMER, macrophage M2 in QUANTISEQ, CD4+ memory T cell, CD8+ T cell, and myeloid dendritic cell in MCPCOUNTER, myeloid dendritic cell activated, B cell, T cell CD4+ memory, T cell CD8+, class−switched memory B cell, myeloid dendritic cell, cancer-associated fibroblast, hematopoietic stem cell, B cell memory, T cell NK, and T cell CD4+ Th1 for XCELL, as well as macrophage to EPIC.